Alexion Pharma is a pharmaceutical company based in Stockholm, specializing in the development of therapies for rare diseases. As part of the AstraZeneca Rare Disease division, the company focuses on delivering innovative treatments that aim to significantly improve the lives of patients affected by these conditions. Alexion Pharma is committed to advancing research and development in this field, emphasizing the importance of scientific innovation to enhance treatment options.
The company collaborates with various partners in the healthcare sector to further its mission of supporting patients and caregivers. Alexion Pharma has made a considerable impact on the lives of over 400 million individuals worldwide who are affected by rare diseases. In addition to its therapeutic focus, the organization provides resources and information to assist patients and their families, ensuring they have access to necessary support and guidance throughout their treatment journey.